
Cloram1%
Ibn-Sina Pharmaceuticals Ltd.
Ophthalmic (Eye Drops / Eye Ointment) — Established Use Chloramphenicol eye drops (0.5%) and eye ointment (1%) are indicated for the treatment of superficial bacterial infections of the eye and more.
Chloramphenicol eye drops (0.5%) and eye ointment (1%) are indicated for the treatment of superficial bacterial infections of the eye, including bacterial conjunctivitis and other infections of the conjunctiva and/or cornea caused by susceptible organisms such as Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Klebsiella/Enterobacter species, Moraxella lacunata, and Neisseria species. This is an established, guideline-supported first-line topical use. Chloramphenicol eye preparations should not be used for minor infections that would resolve on their own or purely for prophylaxis.
Oral Chloramphenicol is reserved for serious, potentially life-threatening infections caused by organisms susceptible to Chloramphenicol, specifically when safer or less hazardous antimicrobial agents are ineffective, contraindicated, or unavailable. Established/guideline-referenced serious indications include typhoid fever (Salmonella typhi and other Salmonella species), bacterial meningitis due to Haemophilus influenzae, and severe rickettsial infections. Oral Chloramphenicol should never be used for trivial infections such as the common cold, viral influenza, or uncomplicated sore throat, and not used prophylactically. Because of the risk of fatal bone marrow toxicity (see Precautions and Warnings), oral Chloramphenicol is used only under close medical and haematological supervision.
Dosing and administration of Chloramphenicol differ substantially by formulation and by indication, and must always be individualised by a qualified healthcare professional — the regimens below are general reference ranges, not a one-size-fits-all prescription. Ophthalmic Chloramphenicol is used topically in the eye at fixed intervals for a limited course, while oral Chloramphenicol is dosed by body weight and requires close monitoring because of the serious systemic risks of oral Chloramphenicol.
Common: Transient burning or stinging on application, eye redness (conjunctival hyperemia), itching, and mild irritation.
Serious — seek medical attention: Signs of allergic or hypersensitivity reaction (rash, swelling, vesicular or maculopapular dermatitis around the eye); with prolonged or repeated ophthalmic courses, rare blood dyscrasias have been reported (see Precautions and Warnings — bone marrow toxicity) — stop Chloramphenicol and seek medical advice if unusual bruising, bleeding, or infection symptoms occur.
Common: Nausea, vomiting, diarrhea, and headache; mild skin rash.
Serious — seek medical attention immediately: Signs of bone marrow suppression or aplastic anemia such as unusual bruising or bleeding, sore throat, fever, or unusual tiredness (see Precautions and Warnings for the full explanation); optic neuritis (blurred or reduced vision) and peripheral neuropathy with prolonged therapy; signs of Gray baby syndrome in neonates and young infants — abdominal distension, vomiting, progressive grey-blue skin colour, low body temperature, and cardiovascular collapse (see Pediatric Uses); and signs of severe hypersensitivity/anaphylaxis (difficulty breathing, facial swelling, severe rash).
Chloramphenicol should never be used for trivial infections (such as colds, viral influenza, or uncomplicated throat infections) or as a prophylactic antibiotic; while this is a strong clinical restriction rather than a hypersensitivity-based contraindication, it reflects Chloramphenicol's serious potential toxicity relative to Chloramphenicol's limited benefit in minor illness.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.